Do you recommend the use of dexamethasone and anakinra as upfront treatment in a pediatric patient with secondary HLH (nonrheumatic) who is too ill to tolerate etoposide?
This type of etoposide sparing therapy has been previously described in a case series at https://pubmed.ncbi.nlm.nih.gov/32725881/
1 Answer
Mednet MemberInvited Expert
Rheumatology · University of Alabama at Birmingham
Answered on · Updated on
If there is no concern for new malignancy or systemic infection, then glucocorticoids are reasonable. I use methylprednisolone up to 30 mg/kg/day (max. one gram). Anakinra is a safe and often effective therapy for secondary HLH. It is quick acting and has a short half-life so I use it early. I generally start adults at 100 mg IV/SC every 6 hrs (children 10 mg/kg/day divided q 6 hrs or q 12 hrs if under 20 kg).
Join for free or sign in to see the full answer